FIBROBIOLOGICS INC (FBLG) Stock Price, Quote, News and Overview
NASDAQ:FBLG - Nasdaq - US31573L1052 - Common Stock - Currency: USD
FBLG Quote, Performance and Key Statistics
FIBROBIOLOGICS INC
NASDAQ:FBLG (2/5/2025, 8:00:01 PM)
Premarket: 1.6 -0.05 (-3.03%)1.65
+0.1 (+6.45%)
The current stock price of FBLG is 1.65 USD. In the past month the price decreased by -25.68%. In the past year, price decreased by -76.05%.
FBLG Latest News, Press Releases and Analysis
Stay updated with the stocks that are on the move in today's pre-market session.
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates
FibroBiologics to also present at the BIO CEO & Investor Conference
FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates
FibroBiologics to also present at the BIO CEO & Investor Conference...
FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing
FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing
HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (
FBLG Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.95 | 338.85B | ||
| AMGN | AMGEN INC | 15.53 | 165.46B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 957.73 | 125.79B | ||
| GILD | GILEAD SCIENCES INC | 22.49 | 124.19B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.7 | 78.76B | ||
| ARGX | ARGENX SE - ADR | N/A | 40.17B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.64B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.34B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.26B | ||
| NTRA | NATERA INC | N/A | 23.37B | ||
| BIIB | BIOGEN INC | 8.91 | 21.21B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.55 | 15.81B |
Related stock screener links
About FBLG
Company Profile
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. The company is headquartered in Houston, Texas and currently employs 10 full-time employees. The company went IPO on 2024-01-31. The firm operates as a biopharmaceutical company. The company is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. The company also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.
Company Info
FIBROBIOLOGICS INC
455 E. Medical Center Blvd, Suite 300
Houston TEXAS US
Employees: 10
Company Website: https://fibrobiologics.com/
Investor Relations: http://ir.fibrobiologics.com/sec-filings/all-sec-filings
Phone: 12816715150
FBLG FAQ
What is the stock price of FBLG?
The current stock price of FBLG is 1.65 USD.
What is the symbol for FIBROBIOLOGICS INC stock?
The exchange symbol of FIBROBIOLOGICS INC is FBLG and it is listed on the Nasdaq exchange.
On which exchange is FBLG stock listed?
FBLG stock is listed on the Nasdaq exchange.
Is FBLG a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for FBLG, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of FBLG.
Does FBLG stock pay dividends?
FBLG does not pay a dividend.
What is the Price/Earnings (PE) ratio of FBLG?
FBLG does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.89).
What is the Short Interest ratio of FBLG stock?
The outstanding short interest for FBLG is 9.29% of its float.
FBLG Technical Analysis
FBLG Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to FBLG. Both the profitability and financial health of FBLG have multiple concerns.
FBLG Financial Highlights
Over the last trailing twelve months FBLG reported a non-GAAP Earnings per Share(EPS) of -0.89. The EPS decreased by -321.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -169.83% | ||
| ROE | -649.58% | ||
| Debt/Equity | 0.04 |
FBLG Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to FBLG. The Buy consensus is the average rating of analysts ratings from 9 analysts.